…ere achieved by 37/59 (62.7%) and 33/59 (55.9%) patients in the avacopan group and 34/57 (59.6%) and 30/57 (52.6%) in the prednisone tap…
5articles mentioning drugs
21drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: avacopan ×
avacopan
This drug is selected. Its supporting articles are shown below.
Articles mentioning avacopan
5 articles · page 1 of 1avacopanazathioprinecyclophosphamideprednisonemycophenolate mofetil
AvacopanrituximabcyclophosphamideAAV
…6% vs 51%, p=0.003), including after treatment discontinuation. Avacopan was associated with accelerated glucocorticoid tapering (≤5 mg/…
avacopanavacopan-relatedantineutrophil cytoplasmic antibody-associated vasculitisFood and Drug AdministrationFDA
…Objective Postmarketing safety data of avacopan, the first Food and Drug Administration (FDA) approved drug in …
avacopanTavneosNew England Journal of MedicinevasculitisNEJM
…A crucial study that enabled the vasculitis drug avacopan, branded as Tavneos, to gain regulatory approval has been retra…
avacopancorticosteroidsintravenous cyclophosphamiderituximabgranulomatosis with polyangiitishypertrophic pachymeningitissigmoid sinus thrombosisprogressive mononeuritis multiplexvasculitisdiffuse alveolar haemorrhage
…quently gave intravenous rituximab and C5a receptor antagonist, avacopan. He recovered well and remains in remission.…